MannKind (MNKD) Earnings Date & Reports

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MNKD is expected to report earnings to fall 150.00% to 0 cents per share on November 10

Q3'26

Est.

$0.00

Q2'26

Est.

$-0.01

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.01

Q3'25

Beat

by $0.05

The last earnings report on August 05 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 5.80M shares outstanding, the current market capitalization sits at 1.07B.

View a ticker or compare two or three

MNKD

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for MNKD